Legal & General Group PLC Kura Oncology, Inc. Transaction History

Legal & General Group PLC

$368 Billion
Q4 2024

A detailed history of Legal & General Group PLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 53,980 shares of KURA stock, worth $445,335. This represents 0.0% of its overall portfolio holdings.

Number of Shares

53,980

Previous 58,643 7.95%

Holding current value

$445,335

Previous $1.15 Million 58.95%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$8.51 - $19.21 $39,682 - $89,576	-4,663 Reduced 7.95%	53,980 $470,000
Q3 2024 Nov 14, 2024	SELL	$18.57 - $23.23 $29,897 - $37,400	-1,610 Reduced 2.67%	58,643 $1.15 Million
Q2 2024 Aug 14, 2024	BUY	$17.53 - $22.98 $128,600 - $168,581	7,336 Added 13.86%	60,253 $1.24 Million
Q1 2024 May 14, 2024	SELL	$13.42 - $23.53 $8,964 - $15,718	-668 Reduced 1.25%	52,917 $1.13 Million
Q3 2023 Nov 14, 2023	SELL	$8.44 - $11.86 $1,046 - $1,470	-124 Reduced 0.23%	53,585 $488,000
Q2 2023 Aug 14, 2023	BUY	$9.62 - $13.99 $187,955 - $273,336	19,538 Added 57.18%	53,709 $568,000
Q1 2023 May 15, 2023	BUY	$10.71 - $14.6 $126,356 - $172,250	11,798 Added 52.73%	34,171 $417,000
Q4 2022 Feb 14, 2023	BUY	$11.23 - $16.9 $9,624 - $14,483	857 Added 3.98%	22,373 $277,000
Q3 2022 Nov 14, 2022	BUY	$12.01 - $19.45 $12,598 - $20,403	1,049 Added 5.13%	21,516 $294,000
Q2 2022 Aug 22, 2022	BUY	$10.71 - $18.33 $13,119 - $22,454	1,225 Added 6.37%	20,467 $376,000
Q3 2021 Nov 15, 2021	BUY	$15.42 - $21.72 $171,516 - $241,591	11,123 Added 137.0%	19,242 $360,000
Q2 2021 Aug 12, 2021	SELL	$20.85 - $29.88 $36,320 - $52,050	-1,742 Reduced 17.67%	8,119 $169,000
Q1 2021 May 17, 2021	BUY	$24.75 - $39.14 $11,162 - $17,652	451 Added 4.79%	9,861 $278,000
Q4 2020 Feb 12, 2021	BUY	$29.0 - $41.62 $26,303 - $37,749	907 Added 10.67%	9,410 $307,000
Q3 2020 Nov 13, 2020	SELL	$16.3 - $30.64 $37,653 - $70,778	-2,310 Reduced 21.36%	8,503 $261,000
Q2 2020 Aug 14, 2020	BUY	$7.95 - $18.81 $32,650 - $77,252	4,107 Added 61.24%	10,813 $176,000
Q1 2020 May 14, 2020	SELL	$6.45 - $14.04 $7,423 - $16,160	-1,151 Reduced 14.65%	6,706 $64,000
Q4 2019 Feb 13, 2020	BUY	$12.97 - $15.94 $16,484 - $20,259	1,271 Added 19.3%	7,857 $108,000
Q3 2019 Nov 13, 2019	BUY	$14.75 - $20.87 $10,103 - $14,295	685 Added 11.61%	6,586 $100,000
Q2 2019 Aug 14, 2019	BUY	$14.71 - $19.79 $6,016 - $8,094	409 Added 7.45%	5,901 $116,000
Q1 2019 May 15, 2019	BUY	$13.73 - $16.87 $4,352 - $5,347	317 Added 6.13%	5,492 $91,000
Q4 2018 Feb 15, 2019	BUY	$10.6 - $17.49 $9,783 - $16,143	923 Added 21.71%	5,175 $73,000
Q3 2018 Nov 20, 2018	BUY	$16.65 - $21.85 $8,641 - $11,340	519 Added 13.9%	4,252 $74,000
Q2 2018 Aug 10, 2018	SELL	$14.8 - $18.8 $1,154 - $1,466	-78 Reduced 2.05%	3,733 $68,000
Q1 2018 May 17, 2018	SELL	$14.5 - $23.4 $18,038 - $29,109	-1,244 Reduced 24.61%	3,811 $71,000
Q4 2017 Feb 13, 2018	BUY	$13.5 - $16.65 $68,242 - $84,165	5,055	5,055 $79,000

Others Institutions Holding KURA

# of Institutions

193

Shares Held

77.5M

Call Options Held

103K

Put Options Held

106K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $552M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Kura Oncology, Inc. Transaction History